Key features and details
- Rabbit polyclonal to Myosin light chain kinase/MLCK (phospho S1760)
- Suitable for: WB
- Reacts with: Mouse, Rabbit, Cow
- Isotype: IgG
Product nameAnti-Myosin light chain kinase/MLCK (phospho S1760) antibody
See all Myosin light chain kinase/MLCK primary antibodies
DescriptionRabbit polyclonal to Myosin light chain kinase/MLCK (phospho S1760)
Tested applicationsSuitable for: WBmore details
Species reactivityReacts with: Mouse, Rabbit, Cow
Predicted to work with: Human
Synthetic peptide corresponding to Human Myosin light chain kinase/MLCK (phospho S1760). A phosphopeptide derived from the region of Human Myosin light chain kinase/ MLCK that contains serine 1760.
Database link: Q15746
- KCl-treated rabbit muscle extracts; COS cells over-expressing rabbit smooth muscle short Myosin light chain kinase/MLCK, phosphorylated in vitro by PKA.
Previously labelled as Myosin light chain kinase.
Reproducibility is key to advancing scientific discovery and accelerating scientists’ next breakthrough.
Abcam is leading the way with our range of recombinant antibodies, knockout-validated antibodies and knockout cell lines, all of which support improved reproducibility.
We are also planning to innovate the way in which we present recommended applications and species on our product datasheets, so that only applications & species that have been tested in our own labs, our suppliers or by selected trusted collaborators are covered by our Abpromise™ guarantee.
In preparation for this, we have started to update the applications & species that this product is Abpromise guaranteed for.
We are also updating the applications & species that this product has been “predicted to work with,” however this information is not covered by our Abpromise guarantee.
Applications & species from publications and Abreviews that have not been tested in our own labs or in those of our suppliers are not covered by the Abpromise guarantee.
Please check that this product meets your needs before purchasing. If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, as well as customer reviews and Q&As.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferpH: 7.30
Preservative: 0.05% Sodium azide
Constituents: 50% Glycerol, 0.1% BSA, 49% PBS
Concentration information loading...
PurityImmunogen affinity purified
Purification notesab200809 has been negatively preadsorbed using a non-phosphopeptide corresponding to the site of phosphorylation to remove antibody that is reactive with non-phosphorylated Myosin light chain kinase/MLCK.
Our Abpromise guarantee covers the use of ab200809 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000. Predicted molecular weight: 211 kDa.|
FunctionCalcium/calmodulin-dependent enzyme implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activty (By similarity). Implicated in the regulation of endothelial as well as vascular permeability. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis.
Tissue specificitySmooth muscle and non-muscle isozymes are expressed in a wide variety of adult and fetal tissues and in cultured endothelium with qualitative expression appearing to be neither tissue- nor development-specific. Non-muscle isoform 2 is the dominant splice variant expressed in various tissues. Telokin has been found in a wide variety of adult and fetal tissues.
Sequence similaritiesBelongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family.
Contains 1 fibronectin type-III domain.
Contains 9 Ig-like C2-type (immunoglobulin-like) domains.
Contains 1 protein kinase domain.
modificationsMLCK is probably down-regulated by phosphorylation.
The C-terminus is deglutamylated by AGTPBP1/ CCP1, AGBL1/CCP4 and AGBL4/CCP6, leading to the formation of Myosin light chain kinase, smooth muscle, deglutamylated form. The consequences of C-terminal deglutamylation are unknown.
- Information by UniProt
- deglutamylated form antibody
- DKFZp686I10125 antibody
- EC 18.104.22.168 antibody
All lanes : Anti-Myosin light chain kinase/MLCK (phospho S1760) antibody (ab200809) at 1/1000 dilution
Lane 1 : Extracts of COS cells transfected with rabbit muscle Myosin light chain kinase/MLCK, unstimulated
Lane 2 : Extracts of COS cells transfected with rabbit muscle Myosin light chain kinase/MLCK phosphorylated in vitro by 0.05 µg of PKA
Lane 3 : Extracts of COS cells transfected with rabbit muscle Myosin light chain kinase/MLCK phosphorylated in vitro by 0.05 µg of PKA with the non-phosphopeptide corresponding to the phosphopeptide immunogen
Lane 4 : Extracts of COS cells transfected with rabbit muscle Myosin light chain kinase/MLCK phosphorylated in vitro by 0.05 µg of PKA with a generic phosphoserine-containing peptide
Lane 5 : Extracts of COS cells transfected with rabbit muscle Myosin light chain kinase/MLCK phosphorylated in vitro by 0.05 µg of PKA with the phosphopeptide immunogen
Lane 6 : Extracts of COS cells transfected with rabbit muscle Myosin light chain kinase/MLCK phosphorylated in vitro by 0.05 µg of PKA, treated with
All lanes : goat F(ab’)2 anti-rabbit IgG HRP
Predicted band size: 211 kDa
Resolved by SDS-PAGE on a 4-12% Tris-glycine gel and transferred to PVDF. The membrane was left untreated (Lanes 1-5) or treated with lambda phophatase (Lane 6), blocked with a 5% BSA-TBST buffer for one hour at room temperature and then incubated with ab200809 for two hours at room temperature in 3% BSA-TBST buffer.
N.B. 0.05 μg of PKA (per μg of extract) for 10 minutes at 37 ºC.
ab200809 has been referenced in 2 publications.
- Cheng YC et al. Magnolol Inhibits Human Glioblastoma Cell Migration by Regulating N-Cadherin. J Neuropathol Exp Neurol 77:426-436 (2018). PubMed: 29788114
- Boire A et al. Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis. Cell 168:1101-1113.e13 (2017). PubMed: 28283064